Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-re...
Saved in:
Main Authors: | Patel, Nish, Chatterjee, Sabarni K., Vrbanac, Vladimir, Chung, Ivy, Mu, Chunyao Jenny, Olsen, Rachelle R., Waghorne, Carol, Zetter, Bruce R. |
---|---|
Format: | Article |
Published: |
National Academy of Sciences
2010
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/5085/ https://doi.org/10.1073/pnas.0910649107 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
China: Pandemic and repression, biopower and governmentality
by: Yeoh, Emile Kok Kheng
Published: (2021) -
Inhibition of Chromobacterium violaceum antibiotics production by catabolite repression
by: Loke, Wai Keong, et al.
Published: (2009) -
Eurycomanone suppresses expression of Lung Cancer Cell Tumor Markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28
by: Wong, P.F., et al.
Published: (2012) -
Modeling of Hyaluronan-Paclitaxel
Targeted Delivery to Cancer Cells
by: Nasarudin, Nurliyana
Published: (2012) -
Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment
by: Chowdhury, M.R., et al.
Published: (2018)